Cameron C. Lee
Molecular Biology · 2005–2006
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 18 citations into it
- Biomaterials — 7 citations into it
Whom Cameron C. Lee trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Cameron C. Lee overall
Papers from Cameron C. Lee's perspective
Ordered by how strongly the researchers Cameron C. Lee trusts endorse each paper. Same corpus, a different order for every researcher.
- The dawning era of polymer therapeutics (Nature reviews. Drug discovery)
- The cluster glycoside effect. (Chemical Reviews)
- The influence of surface modification on the cytotoxicity of PAMAM dendrimers. (International journal of pharmaceutics)
- Ligand-targeted therapeutics in anticancer therapy (Nature Reviews. Cancer)
- Delivering nanomedicine to solid tumors (Nature Reviews Clinical Oncology)
- Drug Delivery Systems: Entering the Mainstream (Science)
- Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. (Cancer Research)
- TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors (Proceedings of the National Academy of Sciences of the United States of America)
- Openings between defective endothelial cells explain tumor vessel leakiness. (American Journal of Pathology)
- RNAi-mediated gene silencing in non-human primates (Nature)
Their papers
- A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas (2006) — 604 citations
- Designing dendrimers for biological applications (2005) — 1,898 citations